-
1
-
-
84858766182
-
The blockade of immune checkpoints in cancer immunotherapy
-
PMID:22437870
-
Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012; 12:252-64; PMID:22437870; http://dx.doi.org/10.1038/ nrc3239
-
(2012)
Nat Rev Cancer
, vol.12
, pp. 252-264
-
-
Pardoll, D.M.1
-
2
-
-
33747135818
-
Therapeutic potential of immunostimulatory monoclonal antibodies
-
PMID: 16831129
-
Gray JC, Johnson PW, Glennie MJ. Therapeutic potential of immunostimulatory monoclonal antibodies. Clin Sci (Lond) 2006; 111:93-106; PMID: 16831129; http://dx.doi.org/10.1042/CS20060024
-
(2006)
Clin Sci (Lond)
, vol.111
, pp. 93-106
-
-
Gray, J.C.1
Johnson, P.W.2
Glennie, M.J.3
-
3
-
-
33748416499
-
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
-
PMID:16908486
-
Suntharalingam G, Perry MR, Ward S, Brett SJ, Cas-tello-Cortes A, Brunner MD, Panoskaltsis N. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006; 355:1018-28; PMID:16908486; http://dx.doi.org/10.1056/ NEJMoa063842
-
(2006)
N Engl J Med
, vol.355
, pp. 1018-1028
-
-
Suntharalingam, G.1
Perry, M.R.2
Ward, S.3
Brett, S.J.4
Cas-tello-Cortes, A.5
Brunner, M.D.6
Panoskaltsis, N.7
-
4
-
-
37749032491
-
"Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: Better understanding the causes to improve preclinical testing of immunotherapeutics
-
PMID: 17709549
-
Stebbings R, Findlay L, Edwards C, Eastwood D, Bird C, North D, Mistry Y, Dilger P, Liefooghe E, Cludts I, et al. "Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics. J Immunol 2007; 179:3325-31; PMID: 17709549; http://dx.doi.org/10.4049/jimmunol.179. 5.3325
-
(2007)
J Immunol
, vol.179
, pp. 3325-3331
-
-
Stebbings, R.1
Findlay, L.2
Edwards, C.3
Eastwood, D.4
Bird, C.5
North, D.6
Mistry, Y.7
Dilger, P.8
Liefooghe, E.9
Cludts, I.10
-
5
-
-
43049154225
-
Signaling signatures and functional properties of anti-human CD28 superagonistic antibodies
-
PMID:18320029
-
Waibler Z, Sender LY, Merten C, Hartig R, Kliche S, Gunzer M, Reichardt P, Kalinke U, Schraven B. Signaling signatures and functional properties of anti-human CD28 superagonistic antibodies. PLoS One 2008; 3: e1708; PMID:18320029; http://dx.doi.org/10.1371/ journal.pone.0001708
-
(2008)
PLoS One
, pp. e1708
-
-
Waibler, Z.1
Sender, L.Y.2
Merten, C.3
Hartig, R.4
Kliche, S.5
Gunzer, M.6
Reichardt, P.7
Kalinke, U.8
Schraven, B.9
-
6
-
-
84992157315
-
T cell co-inhibitory receptors: Functions and signalling mechanisms
-
Thaventhiran T, Sethu S, Yeang HXA, Al-Huseini L, Hamdam J, Sathish JG. T Cell Co-inhibitory Receptors: Functions and Signalling Mechanisms. Journal of Clinical and Cellular Immunology 2012; S12
-
(2012)
Journal of Clinical and Cellular Immunology
, pp. S12
-
-
Thaventhiran, T.1
Sethu, S.2
Yeang, H.X.A.3
Al-Huseini, L.4
Hamdam, J.5
Sathish, J.G.6
-
7
-
-
79960906880
-
Role of PD-1 in regulating T-cell immunity
-
PMID:21061197
-
Jin HT, Ahmed R, Okazaki T. Role of PD-1 in regulating T-cell immunity. Curr Top Microbiol Immunol 2011; 350:17-37; PMID:21061197; http://dx.doi.org/ 10.1007/82-2010-116
-
(2011)
Curr Top Microbiol Immunol
, vol.350
, pp. 17-37
-
-
Jin, H.T.1
Ahmed, R.2
Okazaki, T.3
-
8
-
-
42649125225
-
PD-1 and its ligands in tolerance and immunity
-
PMID:18173375
-
Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008; 26:677-704; PMID:18173375; http:// dx.doi.org/10.1146/annurev.immunol.26.021607.090331
-
(2008)
Annu Rev Immunol
, vol.26
, pp. 677-704
-
-
Keir, M.E.1
Butte, M.J.2
Freeman, G.J.3
Sharpe, A.H.4
-
9
-
-
84879703551
-
Strength of PD-1 signaling differentially affects T-cell effector functions
-
PMID:23610399
-
Wei F, Zhong S, Ma Z, Kong H, Medvec A, Ahmed R, Freeman GJ, Krogsgaard M, Riley JL. Strength of PD-1 signaling differentially affects T-cell effector functions. Proc Natl Acad Sci U S A 2013; 110:E2480-9; PMID:23610399; http://dx.doi.org/10.1073/pnas. 1305394110
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
, pp. E2480-E2489
-
-
Wei, F.1
Zhong, S.2
Ma, Z.3
Kong, H.4
Medvec, A.5
Ahmed, R.6
Freeman, G.J.7
Krogsgaard, M.8
Riley, J.L.9
-
10
-
-
77956304908
-
Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4C effector memory T-cells
-
PMID:20880392
-
Eastwood D, Findlay L, Poole S, Bird C, Wadhwa M, Moore M, Burns C, Thorpe R, Stebbings R. Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4C effector memory T-cells. Br J Pharmacol 2010; 161:512-26; PMID:20880392; http://dx.doi.org/10.1111/j.1476-5381.2010.00922.x
-
(2010)
Br J Pharmacol
, vol.161
, pp. 512-526
-
-
Eastwood, D.1
Findlay, L.2
Poole, S.3
Bird, C.4
Wadhwa, M.5
Moore, M.6
Burns, C.7
Thorpe, R.8
Stebbings, R.9
-
11
-
-
84255160968
-
Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412
-
PMID: 21931118
-
Römer PS, Berr S, Avota E, Na SY, Battaglia M, ten Berge I, Einsele H, H €unig T. Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412. Blood 2011; 118:6772-82; PMID: 21931118; http://dx.doi.org/10.1182/blood-2010-12-319780
-
(2011)
Blood
, vol.118
, pp. 6772-6782
-
-
Römer, P.S.1
Berr, S.2
Avota, E.3
Na, S.Y.4
Battaglia, M.5
Ten Berge, I.6
Einsele, H.7
Heuro8
unig, T.9
-
12
-
-
0034288890
-
Triggering the TCR complex causes the downregulation of nonengaged receptors by a signal transduction-dependent mechanism
-
PMID:10714682
-
San José E, Borroto A, Niedergang F, Alcover A, Alarcón B. Triggering the TCR complex causes the downregulation of nonengaged receptors by a signal transduction-dependent mechanism. Immunity 2000; 12:161-70; PMID:10714682; http://dx.doi.org/ 10.1016/S1074-7613(00)80169-7
-
(2000)
Immunity
, vol.12
, pp. 161-170
-
-
San José, E.1
Borroto, A.2
Niedergang, F.3
Alcover, A.4
Alarcón, B.5
-
13
-
-
0242490281
-
Long-term proliferation and survival of in vitro-activated T cells is dependent on Interleukin-2 receptor signalling but not on the high-affinity IL-2R
-
PMID:14629624
-
Hedfors IA, Brinchmann JE. Long-term proliferation and survival of in vitro-activated T cells is dependent on Interleukin-2 receptor signalling but not on the high-affinity IL-2R. Scand J Immunol 2003; 58:522-32; PMID:14629624; http://dx.doi.org/10.1046/ j.1365-3083.2003.01338.x
-
(2003)
Scand J Immunol
, vol.58
, pp. 522-532
-
-
Hedfors, I.A.1
Brinchmann, J.E.2
-
14
-
-
84880688741
-
Severity of the TGN1412 trial disaster cytokine storm correlated with IL-2 release
-
PMID:23701319
-
Eastwood D, Bird C, Dilger P, Hockley J, Findlay L, Poole S, Thorpe SJ, Wadhwa M, Thorpe R, Stebbings R. Severity of the TGN1412 trial disaster cytokine storm correlated with IL-2 release. Br J Clin Pharmacol 2013; 76:299-315; PMID:23701319; http://dx.doi. org/10.1111/bcp.12165
-
(2013)
Br J Clin Pharmacol
, vol.76
, pp. 299-315
-
-
Eastwood, D.1
Bird, C.2
Dilger, P.3
Hockley, J.4
Findlay, L.5
Poole, S.6
Thorpe, S.J.7
Wadhwa, M.8
Thorpe, R.9
Stebbings, R.10
-
15
-
-
34249340148
-
A twosignal model for T cell trafficking
-
PMID:17481953
-
Marelli-Berg FM, Okkenhaug K, Mirenda V. A twosignal model for T cell trafficking. Trends Immunol 2007; 28:267-73; PMID:17481953; http://dx.doi.org/ 10.1016/j.it.2007.04.008
-
(2007)
Trends Immunol
, vol.28
, pp. 267-273
-
-
Marelli-Berg, F.M.1
Okkenhaug, K.2
Mirenda, V.3
-
16
-
-
0041384357
-
LFA-1-induced T cellmigration on ICAM-1 involves regulation of MLCK-mediated attachment and ROCKdependent detachment
-
PMID:12799414
-
Smith A, Bracke M, Leitinger B, Porter JC, Hogg N. LFA-1-induced T cellmigration on ICAM-1 involves regulation of MLCK-mediated attachment and ROCKdependent detachment. J Cell Sci 2003; 116:3123-33; PMID:12799414; http://dx.doi.org/10.1242/jcs.00606
-
(2003)
J Cell Sci
, vol.116
, pp. 3123-3133
-
-
Smith, A.1
Bracke, M.2
Leitinger, B.3
Porter, J.C.4
Hogg, N.5
-
17
-
-
34548304322
-
Role of phosphoinositide 3-kinase signaling in autoimmunity
-
PMID:17729037
-
Oak JS, Fruman DA. Role of phosphoinositide 3-kinase signaling in autoimmunity. Autoimmunity 2007; 40:433-41; PMID:17729037; http://dx.doi.org/ 10.1080/08916930701464780
-
(2007)
Autoimmunity
, vol.40
, pp. 433-441
-
-
Oak, J.S.1
Fruman, D.A.2
-
18
-
-
84869430727
-
PTEN: An intercellular peacekeeper
-
PMID:23150879
-
Leslie NR. PTEN: an intercellular peacekeeper? Sci Signal 2012; 5:pe50; PMID:23150879; http://dx.doi.org/ 10.1126/scisignal.2003685
-
(2012)
Sci Signal
, vol.5
, pp. 50
-
-
Leslie, N.R.1
-
19
-
-
84881308659
-
PD-1 increases PTEN phosphatase activity while decreasing PTEN protein stability by inhibiting casein kinase 2
-
PMID: 23732914
-
Patsoukis N, Li L, Sari D, Petkova V, Boussiotis VA. PD-1 increases PTEN phosphatase activity while decreasing PTEN protein stability by inhibiting casein kinase 2. Mol Cell Biol 2013; 33:3091-8; PMID: 23732914; http://dx.doi.org/10.1128/MCB.00319-13
-
(2013)
Mol Cell Biol
, vol.33
, pp. 3091-3098
-
-
Patsoukis, N.1
Li, L.2
Sari, D.3
Petkova, V.4
Boussiotis, V.A.5
-
20
-
-
0035284888
-
Cutting edge: The class II transactivator prevents activation-induced cell death by inhibiting Fas ligand gene expression
-
PMID:11207239
-
Gourley TS, Chang CH. Cutting edge: the class II transactivator prevents activation-induced cell death by inhibiting Fas ligand gene expression. J Immunol 2001; 166:2917-21; PMID:11207239; http://dx.doi. org/10.4049/jimmunol.166.5.2917
-
(2001)
J Immunol
, vol.166
, pp. 2917-2921
-
-
Gourley, T.S.1
Chang, C.H.2
-
21
-
-
29144455031
-
Tissue trafficking patterns of effector memory CD4C T cells in rheumatoid arthritis
-
PMID:16329093
-
Zhang X, Nakajima T, Goronzy JJ, Weyand CM. Tissue trafficking patterns of effector memory CD4C T cells in rheumatoid arthritis. Arthritis Rheum 2005; 52:3839-49; PMID:16329093; http://dx.doi.org/ 10.1002/art.21482
-
(2005)
Arthritis Rheum
, vol.52
, pp. 3839-3849
-
-
Zhang, X.1
Nakajima, T.2
Goronzy, J.J.3
Weyand, C.M.4
-
22
-
-
79952012299
-
Were monocytes responsible for initiating the cytokine storm in the TGN1412 clinical trial tragedy
-
PMID:20964641
-
Sandilands GP, Wilson M, Huser C, Jolly L, Sands WA, McSharry C. Were monocytes responsible for initiating the cytokine storm in the TGN1412 clinical trial tragedy? Clin Exp Immunol 2010; 162:516-27; PMID:20964641; http://dx.doi.org/10.1111/j.1365-2249.2010.04264.x
-
(2010)
Clin Exp Immunol
, vol.162
, pp. 516-527
-
-
Sandilands, G.P.1
Wilson, M.2
Huser, C.3
Jolly, L.4
Sands, W.A.5
McSharry, C.6
-
23
-
-
79957621253
-
The insider's guide to leukocyte integrin signalling and function
-
PMID:21597477
-
Hogg N, Patzak I, Willenbrock F. The insider's guide to leukocyte integrin signalling and function. Nat Rev Immunol 2011; 11:416-26; PMID:21597477; http:// dx.doi.org/10.1038/nri2986
-
(2011)
Nat Rev Immunol
, vol.11
, pp. 416-426
-
-
Hogg, N.1
Patzak, I.2
Willenbrock, F.3
-
24
-
-
79957574865
-
The negative costimulatory molecule PD-1 modulates the balance between immunity and tolerance via miR-21
-
PMID:21469086
-
Iliopoulos D, Kavousanaki M, Ioannou M, Boumpas D, Verginis P. The negative costimulatory molecule PD-1 modulates the balance between immunity and tolerance via miR-21. Eur J Immunol 2011; 41:1754-63; PMID:21469086; http://dx.doi.org/10.1002/ eji.201040646
-
(2011)
Eur J Immunol
, vol.41
, pp. 1754-1763
-
-
Iliopoulos, D.1
Kavousanaki, M.2
Ioannou, M.3
Boumpas, D.4
Verginis, P.5
-
25
-
-
36749010774
-
Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability
-
PMID:17968013
-
Pentcheva-Hoang T, Chen L, Pardoll DM, Allison JP. Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability. Proc Natl Acad Sci U S A 2007; 104:17765-70; PMID:17968013; http://dx.doi.org/10.1073/pnas. 0708767104
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 17765-17770
-
-
Pentcheva-Hoang, T.1
Chen, L.2
Pardoll, D.M.3
Allison, J.P.4
-
26
-
-
34447095246
-
Phosphoinositide 3-kinase signalling in lung disease: Leucocytes and beyond
-
PMID:17614878
-
Medina-Tato DA, Ward SG, Watson ML. Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond. Immunology 2007; 121:448-61; PMID:17614878; http://dx.doi.org/10.1111/j.1365-2567.2007.02663.x
-
(2007)
Immunology
, vol.121
, pp. 448-461
-
-
Medina-Tato, D.A.1
Ward, S.G.2
Watson, M.L.3
-
27
-
-
84875720612
-
Challenges and approaches for the development of safer immunomodulatory biologics
-
PMID:23535934
-
Sathish JG, Sethu S, Bielsky MC, de Haan L, French NS, Govindappa K, Green J, Griffiths CE, Holgate S, Jones D, et al. Challenges and approaches for the development of safer immunomodulatory biologics. Nat Rev Drug Discov 2013; 12:306-24; PMID:23535934; http://dx.doi.org/10.1038/nrd3974
-
(2013)
Nat Rev Drug Discov
, vol.12
, pp. 306-324
-
-
Sathish, J.G.1
Sethu, S.2
Bielsky, M.C.3
De Haan, L.4
French, N.S.5
Govindappa, K.6
Green, J.7
Griffiths, C.E.8
Holgate, S.9
Jones, D.10
-
28
-
-
84871122818
-
Antibody C region influences TGN1412-like functional activity in vitro
-
PMID:23150712
-
Ball C, Fox B, Hufton S, Sharp G, Poole S, Stebbings R, Eastwood D, Findlay L, Parren PW, Thorpe R, et al. Antibody C region influences TGN1412-like functional activity in vitro. J Immunol 2012; 189:5831-40; PMID:23150712; http://dx.doi.org/ 10.4049/jimmunol.1201795
-
(2012)
J Immunol
, vol.189
, pp. 5831-5840
-
-
Ball, C.1
Fox, B.2
Hufton, S.3
Sharp, G.4
Poole, S.5
Stebbings, R.6
Eastwood, D.7
Findlay, L.8
Parren, P.W.9
Thorpe, R.10
|